Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Kim Chemicals Private Ltd.
WARNING LETTER
•Kim Chemicals Private Ltd.•June 9, 2017

Kim Chemicals Private Ltd. – FDA Warning Letter, Jun 9, 2017

Record Details

The FDA issued a Warning Letter to Kim Chemicals Private Ltd. following a June 5-9, 2017 inspection of their drug manufacturing facility in Maharashtra, India. The inspection revealed significant violations of current good manufacturing practice (CGMP) regulations, rendering their drug products adulterated.

Key violations include: 1. **Failure to test drug products prior to release (21 CFR 211.165(a))**: Multiple batches of Sofskin Vaporizing Chest Rub and another product failed to meet specifications, including active ingredient content, yet were shipped to the U.S. The firm admitted to not routinely testing batches, instead reusing old test results. 2. **Inadequate Quality Control Unit (21 CFR 211.22(a) and (d))**: The firm lacked an adequate quality control unit and written procedures for critical operations like complaint handling, recalls, out-of-specification investigations, deviations, rejects, returns, and stability. 3. **Incomplete Laboratory Records (21 CFR 211.194(a))**: No records supported analytical testing results on certificates of analysis. The firm indicated destroying original test documentation after transcribing results.

The FDA also identified Sofskin Vaporizing Chest Rub and Sofskin Pure Petroleum Jelly as unapproved new drugs and misbranded drugs. Sofskin Vaporizing Chest Rub's formulation and labeling for nasal decongestant and cough suppressant indications did

Company
Kim Chemicals Private Ltd.
Inspection date
June 9, 2017
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas J. Cosgrove
View Company Profile

ID · cd76d933-1c7c-4c0f-bb3f-f18ca20664f1

Violation Codes10
21 CFR 21021 CFR 211FD&C Act 501(a)(2)(B)FD&C Act 505(a)21.U.S.C. 355(a)FD&C Act 502(x)21 U.S.C. 352(x)21 U.S.C. 352(c)21 CFR 211.165(a)21 CFR 211.22(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kim Chemicals Private Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.